Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$430K Buy
811
+166
+26% +$76.6K ﹤0.01% 537
2026
Q1
$310K Buy
645
+134
+26% +$68.6K ﹤0.01% 642
2025
Q4
$287K Buy
511
+1
+0.2% +$568 ﹤0.01% 669
2025
Q3
$262K Sell
510
-6
-1% -$2.62K ﹤0.01% 705
2025
Q2
$162K Buy
516
+49
+10% +$14.7K ﹤0.01% 843
2025
Q1
$142K Buy
467
+176
+60% +$59.2K ﹤0.01% 845
2024
Q4
$96.7K Sell
291
-374
-56% -$127K ﹤0.01% 954
2024
Q3
$274K Buy
665
+104
+19% +$39.5K ﹤0.01% 717
2024
Q2
$227K Buy
561
+162
+41% +$64.2K ﹤0.01% 658
2024
Q1
$161K Sell
399
-166
-29% -$58.4K ﹤0.01% 577
2023
Q4
$137K Sell
565
-116
-17% -$31.3K ﹤0.01% 567
2023
Q3
$164K Buy
681
+536
+370% +$137K ﹤0.01% 485
2023
Q2
$27K Sell
145
-1,080
-88% -$224K ﹤0.01% 930
2023
Q1
$260K Buy
1,225
+555
+83% +$115K ﹤0.01% 457
2022
Q4
$105K Buy
670
+483
+258% +$96.5K ﹤0.01% 645
2022
Q3
$28K Buy
187
+70
+60% +$11.2K ﹤0.01% 953
2022
Q2
$19K Buy
+117
New +$16.9K ﹤0.01% 970

Other funds holding MEDP

Blue Trust Inc's MEDP Position: Q2 2026 in Review

Blue Trust Inc increased its Medpace (MEDP) stake by 26% in Q2 2026, buying an estimated $76.6K and bringing the position to 811 shares worth $430K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

Blue Trust Inc first reported a position in MEDP in Q2 2022 and has held it in 17 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Blue Trust Inc held 811 shares of Medpace worth $430K as of Q2 2026.
  • Blue Trust Inc bought 166 Medpace shares in Q2 2026, an estimated $76.6K.
  • Medpace made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #537 holding.
  • Blue Trust Inc first reported a position in Medpace in Q2 2022 and has held it in 17 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.